Featured Entrepreneurs

Since 2010, MassChallenge has accelerated 2,458 startups that have raised more than $6.2 billion in funding, generated more than $3+ billion in revenue, and created more than 157,000 total jobs. 

Our startups

Be inspired. Search our startups.


Spinal cord injury (SCI) is a devastating medical condition that causes paralysis, with no effective treatment to restore movement or sensation to patients. Axonis has assembled top experts in the field to develop iPTEN, a pioneering regenerative therapy. iPTEN re-programs severed nerves to stimulate regeneration, leading to functional recovery. Our goal is to complete safety and efficacy studies in primates to launch iPTEN clinical trials by 2021.
Axonis translates breakthrough regeneration research to groundbreaking paralysis therapy, to transform lives of spinal cord injury patients.

Connect with Axonis


2019 Finalist Boston

Sub industry

Therapeutics (Pharma / Biotech)


MassChallenge strengthens the global innovation ecosystem by accelerating high-potential startups across all industries, from anywhere in the world.